Expression and Diagnostic Value of tRNA-Derived Fragments Secreted by Extracellular Vesicles in Hypopharyngeal Carcinoma

References

• Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34(2):270–281. doi:10.1002/hed.21613
   PubMed Web of Science ®Google Scholar
• Hall SF, Groome PA, Irish J, et al. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope. 2010;118(8):1362–1371. doi:10.1097/MLG.0b013e318173dc4a
   Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015;40:41–51. doi:10.1016/j.semcdb.2015.02.010
   PubMed Web of Science ®Google Scholar
• Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83(11):1484–1494. doi:10.1016/j.bcp.2011.12.037
   PubMed Web of Science ®Google Scholar
• Zhu L, Qu XH, Sun YL, et al. Novel method for extracting exosomes of hepatocellular carcinoma cells. World J Gastroenterol. 2014;20(21):6651–6657. doi:10.3748/wjg.v20.i21.6651
   PubMed Web of Science ®Google Scholar
• Braicu C, Tomuleasa C, Monroig P, et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ. 2015;22(1):34–45. doi:10.1038/cdd.2014.130
   PubMed Web of Science ®Google Scholar
• Sun C, Fu Z, Wang S, et al. Roles of tRNA-derived fragments in human cancers. Cancer Lett. 2017;4(14):16–25.
   Google Scholar
• Lee YS, Shibata Y, Malhotra A, et al. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 2009;23(22):2639–2649. doi:10.1101/gad.1837609
   PubMed Web of Science ®Google Scholar
• Huang B, Yang H, Cheng X, et al. tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer. Cancer Res. 2017;77(12):3194–3206. doi:10.1158/0008-5472.CAN-16-3146
   PubMed Web of Science ®Google Scholar
• Martens-Uzunova ES, Olvedy M, Jenster G. Beyond microRNA – novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett. 2013;340(2):201–211. doi:10.1016/j.canlet.2012.11.058
   PubMed Web of Science ®Google Scholar
• Mleczko AM, Celichowski P, Bkowska-Ywicka K. Ex-translational function of tRNAs and their fragments in cancer. Acta Biochim Pol. 2014;61(2):211–216. doi:10.18388/abp.2014_1888
   PubMed Web of Science ®Google Scholar
• Goodarzi H, Hoang CB, Zhang S, et al. Modulated expression of specific tRNAs drives gene expression and cancer pro-gression. Cell. 2016;165(6):1416–1427. doi:10.1016/j.cell.2016.05.046
   PubMed Web of Science ®Google Scholar
• Hamamoto T, Hayashi R, Miyazaki M, et al. A clinical study of post-cricoid carcinoma. Acta Otolaryngol. 2015;25(2):171–176.
   Google Scholar
• Mura F, Bertino G, Occhini A, et al. Surgical treatment of hypopharyngeal cancer: a review of the literature and proposal for a decisional flow-chart. Acta Otorhinolaryngol Ital. 2013;33(5):299–306.
   PubMed Web of Science ®Google Scholar
• Jamali Z, Asl Aminabadi N, Attaran R, et al. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2015;51(4):321–331. doi:10.1016/j.oraloncology.2015.01.008
   PubMed Web of Science ®Google Scholar
• Katsoulakis E, Riaz N, Hu M, et al. Hypopharyngeal squamous cell carcinoma: three-dimensional or Intensity-modulated radiotherapy? A single institution’s experience. Laryngoscope. 2016;126(3):620–626. doi:10.1002/lary.25509
   PubMed Web of Science ®Google Scholar
• Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol. 2001;2(11):698–704. doi:10.1016/S1470-2045(01)00560-5
   PubMed Web of Science ®Google Scholar
• van Niel G, Porto-Carreiro I, Simoes S, et al. Exosomes: a common pathway for a specialized function. J Biochem. 2006;140(1):13–21. doi:10.1093/jb/mvj128
   PubMed Web of Science ®Google Scholar
• Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3:15. doi:10.3410/B3-15
   PubMedGoogle Scholar
• Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010;78(2):191–199. doi:10.1038/ki.2010.106
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi:10.1038/cr.2015.82
   PubMed Web of Science ®Google Scholar
• Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017;14(8):455–466. doi:10.1038/nrgastro.2017.71
   PubMed Web of Science ®Google Scholar
• Yin KJ, Hamblin M, Chen YE. Non-coding RNAs in cerebral endothelial pathophysiology: emerging roles in stroke. Neurochem Int. 2014;77:9–16. doi:10.1016/j.neuint.2014.03.013
   PubMed Web of Science ®Google Scholar
• Olvedy M, Scaravilli M, Hoogstrate Y, et al. A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget. 2016;7(17):24766–24777. doi:10.18632/oncotarget.8293
   PubMedGoogle Scholar
• Wang JY, Ma G, Li MH, et al. Plasma tRNA fragments derived from 5′ ends as novel diagnostic biomarkers for early-stage breast cancer. Mol Ther Nucleic Acids. 2020;21:954–964. doi:10.1016/j.omtn.2020.07.026
   PubMedGoogle Scholar
• Kuang MY, Zheng DF, Tao XT, et al. tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas. Int J Cancer. 2019;145(7):1982–1990. doi:10.1002/ijc.32250
   PubMed Web of Science ®Google Scholar
• Zhao CM, Tolkach Y, Schmidt D, et al. tRNA-halves are prognostic biomarkers for patients with prostate cancer. Urol Oncol. 2018;36(11):503.e1–503.e7. doi:10.1016/j.urolonc.2018.08.003
   Web of Science ®Google Scholar